<DOC>
	<DOCNO>NCT00153946</DOCNO>
	<brief_summary>Edaravone , free radical scavenger , novel neuroprotective agent , argatroban selective thrombin inhibitor . Both drug approve Japanese Government , frequently use treatment acute brain infarction Japan . The effect combination therapy drug , however , yet elucidate . This study test safety efficacy combination therapy agent patient acute non-cardioembolic non-lacunar ischemic stroke .</brief_summary>
	<brief_title>Edaravone Argatroban Stroke Therapy Study Acute Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Argatroban</mesh_term>
	<mesh_term>Phenylmethylpyrazolone</mesh_term>
	<mesh_term>Antipyrine</mesh_term>
	<criteria>Acute ischemic stroke &lt; 24 hour onset Measurable neurological deficit cause present attack , range 1 22 NIHSS score admission Definite possible cardiogenic brain infarction Definite lacunar infarction Prior ischemic stroke within 6 month Evidence hemorrhagic brain infarction , epidural hematoma , intracerebral hematoma , intraventricular hemorrhage Severe consciousness disturbance ( semicoma deep coma ) Neurological sign clear spontaneously Disability 2 mRS score index stroke aPTT normal range 1.5 time longer pretreatment value If take oral anticoagulant , INR 1.6 , INR data Treatment urokinase , tPA , heparin , ozagrel sodium , warfarin , antiplatelet except aspirin enrollment Intravascular surgery , surgical operation , hyperbaric oxygen therapy , hypothermia therapy enrollment Serum creatinine &gt; 1.5 mg/dL Severe hepatic cardiac disorder , infectious disorder , dehydration , etc . Neoplasm Pregnancy Hypersensitivity test drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Free Radical Scavenger</keyword>
	<keyword>Selective Thrombin Inhibitor</keyword>
	<keyword>Acute ischemic stroke ( nonlacunar noncardioembolic )</keyword>
</DOC>